Exhibit 99.1
JOINT FILING STATEMENT
We, the undersigned, hereby express our agreement that the attached statement on Schedule 13G relating to the Common Stock of IDEAYA Biosciences, Inc. is filed on behalf of each of us.
Dated: February 13, 2020
Nextech V Oncology, S.C.S., SICAV-SIF
| By: | Nextech V GP S.à r.l. |
| Its: | General Partner |
| By: | /s/ Dalia Bleyer | |
| Dalia Bleyer, Managing Member | ||
| By: | /s/ James Pledger | |
| James Pledger, Managing Member |
| Nextech V GP S.à r.l. | ||
| By: | /s/ Dalia Bleyer | |
| Dalia Bleyer, Managing Member | ||
| By: | /s/ James Pledger | |
| James Pledger, Managing Member | ||
Nextech IV Oncology, S.C.S. SICAV-SIF
| By: | Nextech IV GP S.à r.l. |
| Its: | General Partner |
| By: | /s/ Marc Kriegsmann | |
| Marc Kriegsmann, Managing Member | ||
| By: | /s/ Christoph Kraiker | |
| Christoph Kraiker, Managing Member |
| Nextech IV GP S.à r.l. | ||
| By: | /s/ Marc Kriegsmann | |
| Marc Kriegsmann, Managing Member | ||
| By: | /s/ Christoph Kraiker | |
| Christoph Kraiker, Managing Member | ||
| /s/ Thomas Lips | |
| Thomas Lips | |
| /s/ James Pledger | |
| James Pledger | |
| /s/ Dalia Bleyer | |
| Dalia Bleyer | |
| /s/ Marc Kriegsmann | |
| Marc Kriegsmann | |
| /s/ Christoph Kraiker | |
| Christoph Kraiker |
